|

AVZO-1418 Clinical Trials

1 actively recruiting trial across 1 location

No change since May 2026

Pipeline

Phase 1/2: 1

Top Sponsors

  • Avenzo Therapeutics, Inc.1

Indications

  • Nasopharyngeal Cancers1
  • Epithelial Tumor1
  • Biliary Tract Cancer (BTC)1
  • Solid Tumor Cancer1
  • Metastatic Solid Tumors1

Gilbert, Arizona1 trial

AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)

Avenzo Therapeutics Recruiting Site

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.